4,8-DIAMINO-1,5-DIHYDROXY-2-(4-HYDROXY-3-METHYLPHENYL)-9,10-ANTHRACENEDIONE
UNII X7JG8WE7JB
Substance Identification & Data
This profile provides standardized clinical and technical data for 4,8-diamino-1,5-dihydroxy-2-(4-hydroxy-3-methylphenyl)-9,10-anthracenedione, uniquely identified by the FDA Unique Ingredient Identifier (UNII) X7JG8WE7JB.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 4702-65-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C21H16N2O5 WSZULUJFSWLUAF-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4,8-diamino-1,5-dihydroxy-2-(4-hydroxy-3-methylphenyl)-9,10-anthracenedione. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.